Logo
Logo

About Ropinirole Hydrochloride API

Product
  • Therapeutic CategoryCentral Nervous System (CNS)

  • CAS Number

    91374-20-8

  • API Technology

    Synthetic

  • Dose Form

    Oral Solids

  • Dr Reddy's Development Status

    Available

Mechanism of Action

opinirole is a non-ergoline dopamine agonist. Ropinirole has the highest affinity at the D3 receptors, which are concentrated in the limbic areas of the brain and may be responsible for some of the neuropsychiatric effects 4. The exact mechanism of action of ropinirole as a treatment for Parkinson’s disease is unknown, however, it is believed to be related to its ability to selectively stimulate dopamine D2 receptors within the caudate-putamen system in the brain. This system affects body movement. Negligible affinity is seen for ropinirole at α2 adrenoreceptors in the periphery and 5HT-1 receptor. Ropinirole has no affinity at the D1-like receptors, benzodiazepine or GABA receptors 4.

The precise mechanism of action of ropinirole as a treatment for Restless Legs Syndrome is unknown, however, it is believed to be related to its ability to stimulate dopamine receptors

Indication

For the treatment of the signs and symptoms of Parkinson's disease and for the treatment of primary moderate-severe restless legs syndrome

Related APIs

Atomoxetine Hydrochloride

Central Nervous System (CNS)

arrow

Benztropine Mesylate

Central Nervous System (CNS)

arrow

Dimethyl Fumarate

Central Nervous System (CNS)

arrow

Edaravone

Central Nervous System (CNS)

arrow

Eslicarbazepine Acetate

Central Nervous System (CNS)

arrow

Eszopiclone

Central Nervous System (CNS)

arrow

Levetiracetam

Central Nervous System (CNS)

arrow

Lumateperone Tosylate

Central Nervous System (CNS)

arrow

Lurasidone Hydrochloride

Central Nervous System (CNS)

arrow

Memantine Hydrochloride

Central Nervous System (CNS)

arrow

Pregabalin

Central Nervous System (CNS)

arrow

Rimegepant

Central Nervous System (CNS)

arrow

Risperidone

Central Nervous System (CNS)

arrow

Rivastigmine Hydrogen Tartrate

Central Nervous System (CNS)

arrow

Ropinirole Hydrochloride

Central Nervous System (CNS)

arrow

Sugammadex Sodium

Central Nervous System (CNS)

arrow

Tizanidine Hydrochloride

Central Nervous System (CNS)

arrow

Xanomeline

Central Nervous System (CNS)

arrow

Fluoxetine

Central Nervous System (CNS)

arrow

Quetiapine Fumarate

Central Nervous System (CNS)

arrow

Apremilast (form B)

Central Nervous System (CNS)

arrow

Donepezil Hydrochloride

Central Nervous System (CNS)

arrow

Siponimod Hemifumarate

Central Nervous System (CNS)

arrow

Ziprasidone Hydrochloride Anhydrous

Central Nervous System (CNS)

arrow

Request for Quotation

Get in touch with us by filling out the form below. Our team will reach out to you shortly!

Phone

Disclaimer

No information on this website, including any reference to any product or service constitutes an offer for sale or be construed as representing an offer for sale. Products protected under valid patents are not offered or supplied for commercial use. However, in certain cases, at Dr. Reddy's sole discretion, and subject to local legal requirement, the research quantities of such products may be offered for the purpose of regulatory submissions under Section 107A of the Indian Patent Act (Bolar exemption), wherever such regulatory exemptions exist. The buyers should make their independent evaluation of the product or service including, patent scenario in their respective markets and will be responsible for all patent related liabilities Dr. Reddy's disclaims all warranties, express or implied, including but not limited to warranties of merchantability, fitness for a particular purpose and non-infringement.

Disclaimer: Products under patent(s) are offered only for R&D purposes U/S 107A of the Patent Act (Bolar Exemption) and not for commercial sale.